Carine Chaleteix
Papers
1
Total Citations
16
H-Index
1
About
Dr. Carine Chaleteix is a distinguished hematologist and researcher whose work has significantly advanced the understanding of myeloproliferative neoplasms (MPNs) and chronic myeloid leukemia (CML). Her key research focuses on the molecular mechanisms and clinical management of these blood disorders, particularly the interplay between different genetic mutations. Her most notable contribution, the 2009 paper "A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2V617F myeloproliferative neoplasm," has garnered 16 citations and remains a seminal observation in the field. This work demonstrated that patients with Philadelphia chromosome-positive CML achieving molecular remission on imatinib could develop an independent JAK2V617F-positive MPN, challenging prior assumptions about disease exclusivity and guiding diagnostic vigilance. Dr. Chaleteix’s research has provided critical insights into clonal heterogeneity and treatment resistance, influencing clinical practice for managing dual-pathology cases. Her contributions have been recognized through collaborations with leading hematology centers, and her findings continue to inform the approach to monitoring and treating patients with overlapping myeloproliferative disorders, making her a respected voice in the hematology community.
Research Focus
Key Achievements
Top Papers
- 1